Data Collective IV GP, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Data Collective IV GP, LLC reported 6 stock positions worth $142.7 million. Its top holding was Oklo (OKLO) at 41.1% of the portfolio, followed by Recursion Pharmaceuticals-A (RXRX, 31.2%) and Evolv Technologies (EVLV, 17.3%). Compared with Q1 2024, it opened 1 new position. The biggest buy was a new position in Oklo (OKLO).
- Most Recent 13F
- Q2 2026
- Location
- PALO ALTO, CA
- CIK
- 0001664974
- Portfolio Value
- $142.7M (Q2 2024)
- SEC Filing
- 0001104659-24-089304 ↗ filed Aug 14, 2024
Holdings Value
Holdings 6 stocks · $142.7M
| OKLO Oklo Inc. | 41.08% | 6,920,804 | $58.6M | New |
| RXRX Recursion Pharmaceuticals-A | 31.23% | 5,941,120 | $44.6M | No change |
| EVLV Evolv Technologies Holdings | 17.30% | 9,681,281 | $24.7M | No change |
| RKLB Rocket Lab USA Inc. | 9.85% | 2,929,350 | $14.1M | No change |
| MIND MEDICINE MINDMED INC | 0.51% | 100,350 | $724K | No change |
| ROIV Roivant Sciences Ltd. | 0.03% | 3,875 | $41K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| OKLO Oklo Inc. | New | 41.08% | +41.08 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $78.6M | EVLV, HQ, RXRX, DFTX |
| Q1 2026 | 4 | $55.9M | EVLV, RXRX, HQ, DFTX |
| Q4 2025 | 3 | $58.5M | EVLV, RXRX, MIND MEDICINE MINDMED INC |
| Q3 2025 | 4 | $68.0M | EVLV, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q2 2025 | 5 | $129.9M | EVLV, RKLB, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q1 2025 | 5 | $86.9M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |
| Q4 2024 | 6 | $226.3M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q3 2024 | 6 | $163.5M | OKLO, EVLV, RXRX, RKLB, MIND MEDICINE MINDMED INC |
| Q2 2024 | 6 | $142.7M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q1 2024 | 5 | $115.3M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |